<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//ES//DTD journal article DTD version 5.0.2//EN//XML" "art502.dtd" [<!ENTITY gr1 SYSTEM "gr1" NDATA IMAGE><!ENTITY gr2a SYSTEM "gr2a" NDATA IMAGE><!ENTITY gr2bc SYSTEM "gr2bc" NDATA IMAGE><!ENTITY gr3 SYSTEM "gr3" NDATA IMAGE><!ENTITY gr4 SYSTEM "gr4" NDATA IMAGE>]>
<article docsubtype="sco" xml:lang="en">
	<ce:floats xmlns:ce="http://www.elsevier.com/xml/common/dtd">
		<ce:figure id="fig1">
			<ce:label>Fig. 1</ce:label>
			<ce:caption>
				<ce:simple-para>
					Expression of MT5-MMP mRNA in NT2 and hNT cells. (A) Phase contrast
					image of NT2 cells prior to differentiation. (B) Phase contrast
					image of differentiated hNT neurons. (C) Verification of
					differentiation by synaptophysin protein expression by western blot
					analysis. Cyclophilin A was used as an internal control. (D)
					MT5-MMP mRNA levels in NT2 and hNT cells. Primer sequences and
					expected amplicon sizes listed in
					<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
					, “Real Time PCR”. Results expressed as the ratio of MT5-MMP
					expression over cyclophilin A (means
					<ce:hsp sp="0.25" />
					±
					<ce:hsp sp="0.25" />
					S.D.),
					<ce:italic>n</ce:italic>
					<ce:hsp sp="0.25" />
					=
					<ce:hsp sp="0.25" />
					3.
				</ce:simple-para>
			</ce:caption>
			<ce:link locator="gr1" />
		</ce:figure>
		<ce:figure id="fig2">
			<ce:label>Fig. 2</ce:label>
			<ce:caption>
				<ce:simple-para>
					Isolation of a novel human MT5-MMP transcript from NT2 cells. (A)
					Visualization of 1779
					<ce:hsp sp="0.25" />
					bp PCR product obtained from cloning reaction (1% agarose, 0.5
					<ce:hsp sp="0.25" />
					μg/ml Ethidium Bromide). Primer sequences and expected amplicon
					sizes listed in
					<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
					, “full cDNA”. (B) 5′ end DNA alignment of MT5-MMP previously
					reported and MT5-MMPvar. (C) Amino acid code with corresponding
					schematic for published MT5-MMP (top panel) and MT5-MMPvar (bottom
					panel). Underline, amino acids that are deleted from MT5-MMPvar.
					<ce:sup loc="pre">∗</ce:sup>
					, arginine residues found at deletion site; Box, peptide sequence
					used for antibody production; Bold underline, Y to H amino acid
					change.
					<ce:italic>Protein domains: Si, signal; Pro, Propeptide; Cat,
						Catalytic; H, Hinge; Pex, Hemopexin; S, Stem; T, Transmembrane; C,
						Cytoplasmic tail.</ce:italic>
				</ce:simple-para>
			</ce:caption>
			<ce:link locator="gr2" />
		</ce:figure>
		<ce:figure id="fig3">
			<ce:label>Fig. 3</ce:label>
			<ce:caption>
				<ce:simple-para>
					Analysis of the 5′ region of MT5-MMP cDNA in NT2, hNT and adult
					human tissues. RT-PCR results show amplification of the divergent
					region of the MT5-MMP gene. Primer sequences and expected amplicon
					sizes listed in
					<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
					, “5′ End”. H1–H4, independent hippocampal surgical samples.
				</ce:simple-para>
			</ce:caption>
			<ce:link locator="gr3" />
		</ce:figure>
		<ce:figure id="fig4">
			<ce:label>Fig. 4</ce:label>
			<ce:caption>
				<ce:simple-para>
					Translation of MT5-MMPvar cDNA. (A) Schematic representation of
					MT5-MMPvar cDNA fused with a C-terminal tag containing a V5
					epitope. (B) IPTG (1
					<ce:hsp sp="0.25" />
					mM) induction of protein synthesis in bacteria containing
					MT5-MMPvar/V5 fusion construct resulted in a ∼55
					<ce:hsp sp="0.25" />
					kDa protein species recognized by an antibody specific to the V5
					epitope. (C) Western blot analysis of MT5-MMP in NT2 and hNT cells
					using an antibody developed from a peptide specific to the region
					which spans the deletion site. Antibody specificity was examined by
					peptide competition experiments (C, right panel). Cyclophilin A (17
					<ce:hsp sp="0.25" />
					kDa) was used as an internal loading control. (D) Densitometric
					analysis was performed to quantitate MT5-MMPvar protein levels in
					NT2 and hNT samples normalized to cyclophilin A.
				</ce:simple-para>
			</ce:caption>
			<ce:link locator="gr4" />
		</ce:figure>
		<ce:figure id="fig5">
			<ce:label>Fig. 5</ce:label>
			<ce:caption>
				<ce:simple-para>
					MT5-MMP protein expression in six independent adult human surgical
					tissues. (A) Western blot analysis of proteins isolated from adult
					hippocampus using the deletion-spanning MT5-MMPvar antibody
					revealed expression of a ∼52
					<ce:hsp sp="0.25" />
					kDa protein in 5 of 6 samples. NT2 served as positive control for
					MT5-MMP expression. (B) Antibody specificity was examined by
					peptide competition. Cyclophilin A (17
					<ce:hsp sp="0.25" />
					kDa) was used as internal control. Lane assignments: 1–6,
					independent surgical samples; 7, NT2 cells.
				</ce:simple-para>
			</ce:caption>
			<ce:link locator="gr5" />
		</ce:figure>
		<ce:table frame="topbot" id="tbl1" rowsep="0" colsep="0">
			<ce:label>Table 1</ce:label>
			<ce:caption>
				<ce:simple-para>Primer design, location and expected sizes for all
					PCR experiments</ce:simple-para>
			</ce:caption>
			<tgroup cols="5">
				<colspec colname="col1" align="left" />
				<colspec colname="col2" align="left" />
				<colspec colname="col3" align="left" />
				<colspec colname="col4" align="left" />
				<colspec colname="col5" align="left" />
				<thead>
					<row rowsep="1" valign="top">
						<entry>Primer set</entry>
						<entry>Primer set application</entry>
						<entry>Sequence</entry>
						<entry>Location</entry>
						<entry>Expected amplicon size</entry>
					</row>
				</thead>
				<tbody>
					<row valign="top">
						<entry morerows="1">A</entry>
						<entry morerows="1">Real time PCR</entry>
						<entry>
							5′
							<ce:monospace>tgagccatggacgctagga</ce:monospace>
							3′
						</entry>
						<entry morerows="1">Spanning intron 4</entry>
						<entry morerows="1">62</entry>
					</row>
					<row valign="top">
						<entry>
							5′
							<ce:monospace>tgcacagccaccaggaaga</ce:monospace>
							3′
						</entry>
					</row>
					<row valign="top">
						<entry morerows="1">B</entry>
						<entry morerows="1">Full cDNA</entry>
						<entry>
							5′
							<ce:monospace>acac</ce:monospace>
							<ce:underline>
								<ce:monospace>atg</ce:monospace>
							</ce:underline>
							<ce:monospace>ccgaggagccggggcg</ce:monospace>
							3′
						</entry>
						<entry morerows="1">Start ATG terminating codon</entry>
						<entry>1938 (MT5-MMP)</entry>
					</row>
					<row valign="top">
						<entry>
							5′
							<ce:monospace>gcacccattcctggactggccgc</ce:monospace>
							3′
							<ce:cross-ref refid="tblfn1">
								<ce:sup>a</ce:sup>
							</ce:cross-ref>
						</entry>
						<entry>1779 (MT5-MMPvar)</entry>
					</row>
					<row valign="top">
						<entry morerows="1">C</entry>
						<entry morerows="1">5′ End</entry>
						<entry>
							5′
							<ce:monospace>acac</ce:monospace>
							<ce:underline>
								<ce:monospace>atg</ce:monospace>
							</ce:underline>
							<ce:monospace>ccgaggagccggggcg</ce:monospace>
							3′
						</entry>
						<entry morerows="1">Start ATG exon 2</entry>
						<entry>1140 (MT5-MMP)</entry>
					</row>
					<row valign="top">
						<entry>
							5′
							<ce:monospace>gttgggtttggtgcctggtgt</ce:monospace>
							3′
						</entry>
						<entry>978 (MT5-MMPvar)</entry>
					</row>
				</tbody>
			</tgroup>
			<ce:table-footnote id="tblfn1">
				<ce:label>a</ce:label>
				<ce:note-para>
					Ref.
					<ce:cross-ref refid="bib12">[12]</ce:cross-ref>
					.
				</ce:note-para>
			</ce:table-footnote>
		</ce:table>
	</ce:floats>
	<head>
		<ce:title xmlns:ce="http://www.elsevier.com/xml/common/dtd">Identification of a novel human MT5-MMP
			transcript variant in multipotent NT2 cells</ce:title>
		<ce:presented xmlns:ce="http://www.elsevier.com/xml/common/dtd">Edited by Takashi Gojobori</ce:presented>
		<ce:author-group xmlns:ce="http://www.elsevier.com/xml/common/dtd">
			<ce:author>
				<ce:given-name>Heather H.</ce:given-name>
				<ce:surname>Ross</ce:surname>
				<ce:cross-ref refid="aff1">
					<ce:sup>a</ce:sup>
				</ce:cross-ref>
				<ce:cross-ref refid="aff2">
					<ce:sup>b</ce:sup>
				</ce:cross-ref>
			</ce:author>
			<ce:author>
				<ce:given-name>Helen L.</ce:given-name>
				<ce:surname>Fillmore</ce:surname>
				<ce:cross-ref refid="aff1">
					<ce:sup>a</ce:sup>
				</ce:cross-ref>
				<ce:cross-ref refid="aff3">
					<ce:sup>c</ce:sup>
				</ce:cross-ref>
				<ce:cross-ref refid="cor1">
					<ce:sup>⁎</ce:sup>
				</ce:cross-ref>
				<ce:e-address type="email">hfillmore@mcvh-vcu.edu</ce:e-address>
			</ce:author>
			<ce:affiliation id="aff1">
				<ce:label>a</ce:label>
				<ce:textfn>Department of Anatomy and Neurobiology, Virginia
					Commonwealth University Medical Center, Richmond, VA, United States</ce:textfn>
			</ce:affiliation>
			<ce:affiliation id="aff2">
				<ce:label>b</ce:label>
				<ce:textfn>Department of Anatomy and Cell Biology, University of
					Florida, Gainesville, FL, United States</ce:textfn>
			</ce:affiliation>
			<ce:affiliation id="aff3">
				<ce:label>c</ce:label>
				<ce:textfn>Department of Neurosurgery, Harold F. Young Neurosurgical
					Center, Virginia Commonwealth University Medical Center, Richmond,
					VA, United States</ce:textfn>
			</ce:affiliation>
			<ce:correspondence id="cor1">
				<ce:label>⁎</ce:label>
				<ce:text>Corresponding author. Address: Harold F. Young
					Neurosurgical Center, Virginia Commonwealth University Medical
					Center, P.O. Box 980631, Richmond VA, United States. Fax: +1 804
					827 1487.</ce:text>
			</ce:correspondence>
		</ce:author-group>
		<ce:abstract class="author" xml:lang="en"
			xmlns:ce="http://www.elsevier.com/xml/common/dtd">
			<ce:section-title>Abstract</ce:section-title>
			<ce:abstract-sec>
				<ce:simple-para>
					Membrane-type 5 matrix metalloproteinase (MT5-MMP) expression is
					ubiquitous in brain development while restricted to regions of
					neuroplasticity in adult. In the multipotent NT2 model of
					neurogenesis and differentiation, MT5-MMP is differentially
					expressed with significantly higher mRNA levels in the
					differentiated neuronal hNT cells. MT5-MMP cDNA cloned from NT2
					cells unexpectedly revealed a novel sequence (MT5-MMPvar)
					characterized by a 162
					<ce:hsp sp="0.25" />
					bp deletion. Both transcripts were identified in NT2, hNT and adult
					human hippocampus. In vitro, MT5-MMPvar translated into a ∼55
					<ce:hsp sp="0.25" />
					kDa protein. It was also detected in NT2, hNT and adult human
					hippocampus. These results suggest more than one human MT5-MMP
					transcript may exist in the central nervous system.
				</ce:simple-para>
			</ce:abstract-sec>
		</ce:abstract>
		<ce:keywords class="abr"
			xmlns:ce="http://www.elsevier.com/xml/common/dtd">
			<ce:section-title>Abbreviations</ce:section-title>
			<ce:keyword>
				<ce:text>CNS</ce:text>
				<ce:keyword>
					<ce:text>central nervous system</ce:text>
				</ce:keyword>
			</ce:keyword>
			<ce:keyword>
				<ce:text>MMP</ce:text>
				<ce:keyword>
					<ce:text>matrix metalloproteinase</ce:text>
				</ce:keyword>
			</ce:keyword>
			<ce:keyword>
				<ce:text>ECM</ce:text>
				<ce:keyword>
					<ce:text>extracellular matrix</ce:text>
				</ce:keyword>
			</ce:keyword>
			<ce:keyword>
				<ce:text>RA</ce:text>
				<ce:keyword>
					<ce:text>
						<ce:italic>all-trans</ce:italic>
						retinoic acid
					</ce:text>
				</ce:keyword>
			</ce:keyword>
		</ce:keywords>
		<ce:keywords class="keyword"
			xmlns:ce="http://www.elsevier.com/xml/common/dtd">
			<ce:section-title>Keywords</ce:section-title>
			<ce:keyword>
				<ce:text>MT5-MMP</ce:text>
			</ce:keyword>
			<ce:keyword>
				<ce:text>MMP24</ce:text>
			</ce:keyword>
			<ce:keyword>
				<ce:text>NT2</ce:text>
			</ce:keyword>
			<ce:keyword>
				<ce:text>CNS</ce:text>
			</ce:keyword>
			<ce:keyword>
				<ce:text>Cloning</ce:text>
			</ce:keyword>
			<ce:keyword>
				<ce:text>Variant</ce:text>
			</ce:keyword>
		</ce:keywords>
	</head>
	<body>
		<ce:sections xmlns:ce="http://www.elsevier.com/xml/common/dtd">
			<ce:section>
				<ce:label>1</ce:label>
				<ce:section-title>Introduction</ce:section-title>
				<ce:para>
					The matrix metalloproteinase (MMP) family of zinc-dependent
					endopeptidases is comprised of 23 members, several of which are
					known to be present in the physiological and pathological central
					nervous system (CNS)
					<ce:cross-refs refid="bib1 bib2">[1,2]</ce:cross-refs>
					. In addition to their established role in extracellular matrix
					(ECM) degradation, the MMP family has a wide range of influences on
					biologic processes including the generation of bioactive proteins
					<ce:cross-refs refid="bib3 bib4 bib5">[3–5]</ce:cross-refs>
					. The most recently identified subfamily of the MMP family is the
					membrane-type MMPs or MT-MMPs reviewed in
					<ce:cross-ref refid="bib6">[6]</ce:cross-ref>
					. MT5-MMP (MMP-24), the fifth cloned MT-MMP, is expressed in few
					tissues including testes, liver, lung and kidney; however, it is
					predominately found in the nervous system
					<ce:cross-refs refid="bib7 bib8 bib9">[7–9]</ce:cross-refs>
					. MT5-MMP expression is ubiquitously expressed during neural
					development; while in the adult CNS, it is restricted to specific
					regions, some of which are known to be neurogenic, such as the
					hippocampus
					<ce:cross-ref refid="bib7">[7]</ce:cross-ref>
					. Previous work further indicates that neuronal MT5-MMP
					participates in plasticity associated with neurite outgrowth
					<ce:cross-ref refid="bib10">[10]</ce:cross-ref>
					.
				</ce:para>
				<ce:para>
					While existing studies have investigated the presence and function
					of MT5-MMP in murine and rodent models, little data is available on
					MT5-MMP expression in the human CNS and neurogenic regions. To
					begin investigations on the role of MT5-MMP in human neurogenesis
					and neural differentiation, we initiated studies using a
					well-characterized neurogenic in vitro model, the NT2 cell line.
					Stimulation of NT2 cells with
					<ce:italic>all-trans</ce:italic>
					retinoic acid (RA) leads to the differentiation of NT2 cells into a
					99% purely post-mitotic neuronal population (hNT cells)
					<ce:cross-ref refid="bib11">[11]</ce:cross-ref>
					.
				</ce:para>
				<ce:para>
					In this report, we show that MT5-MMP mRNA is significantly
					increased in differentiated hNT cells. Analysis of MT5-MMP cDNA
					cloned from NT2 cells resulted in the identification of a novel
					transcript (herein referred to as MT5-MMPvar) differing from that
					of the previously reported MT5-MMP human gene
					<ce:cross-ref refid="bib12">[12]</ce:cross-ref>
					. While 92% homologous to the reported sequence this transcript is
					characterized by a 162
					<ce:hsp sp="0.25" />
					bp deletion within the signal and propeptide domains. Both the
					MT5-MMP and MT5-MMPvar transcripts were identified in NT2 and hNT
					cells and in adult human brain tissue. In vitro
					transcription/translation studies demonstrated the translation of
					an approximately 55
					<ce:hsp sp="0.25" />
					kDa protein from MT5-MMPvar. Western blot analysis using a deletion
					spanning antibody revealed the presence of the corresponding
					MT5-MMPvar protein in NT2 and hNT cells and in adult human
					hippocampus. These results suggest that more than one human MT5-MMP
					transcript may exist in the CNS.
				</ce:para>
			</ce:section>
			<ce:section role="materials-methods">
				<ce:label>2</ce:label>
				<ce:section-title>Materials and methods</ce:section-title>
				<ce:section>
					<ce:label>2.1</ce:label>
					<ce:section-title>NT2 cell culture and human tissue acquisition</ce:section-title>
					<ce:para>
						Undifferentiated NT2/D1 cells were obtained from ATCC (#CRL-1973)
						and maintained in high-glucose DMEM supplemented with 10% FCS/1%
						penicillin/streptomycin. Cells were differentiated according to an
						established protocol
						<ce:cross-ref refid="bib11">[11]</ce:cross-ref>
						. Cells were treated with 10
						<ce:hsp sp="0.25" />
						μmol RA for four weeks. Cells tapped off the flasks were replated
						onto matrigel in the presence of mitotic inhibitors (cytosine
						arabinoside [1
						<ce:hsp sp="0.25" />
						μM], fluorodeoxyuridine [10
						<ce:hsp sp="0.25" />
						μM] and uridine [10
						<ce:hsp sp="0.25" />
						μM]) for 1 week. Cytosine arabinoside was discontinued and
						cultures were maintained for an additional 4 weeks. Cells were
						then replated onto poly-
						<ce:small-caps>l</ce:small-caps>
						-lysine coated six well plates and constituted a 99% pure neuronal
						culture (hNT). Human adult brain tissue was obtained from temporal
						lobe resections in accordance with an approved IRB protocol from
						our institution. Tissue was acutely dissected at the time of
						harvest into samples corresponding to parahippocampal gyrus or
						hippocampal formation. Samples from hippocampal sections were
						subjected to RNA or protein isolation.
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>2.2</ce:label>
					<ce:section-title>Quantitation of MT5-MMP mRNA levels (real time
						PCR)</ce:section-title>
					<ce:para>
						Total RNA was isolated from NT2 cells, hNT cells and adult human
						brain tissue using TRIzol reagent according to the manufacturer’s
						protocol (Invitrogen, CA). RNA was quantitated using
						spectrophotometry and treated with RQ1 DNase (Promega, Madison,
						WI). A primer set complimentary to the human MT5-MMP coding
						sequence (
						<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
						<ce:float-anchor refid="tbl1" />
						A) was designed for automated real time PCR (VCU Nucleic Acid
						Research Facility). Cyclophilin A served as an internal control.
						Results (
						<ce:italic>n</ce:italic>
						<ce:hsp sp="0.25" />
						=
						<ce:hsp sp="0.25" />
						3) were analyzed by Student’s
						<ce:italic>t</ce:italic>
						-test.
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>2.3</ce:label>
					<ce:section-title>Western blot analysis, antibodies and peptide
						competition assay</ce:section-title>
					<ce:para>
						Proteins were isolated from tissue samples as previously described
						<ce:cross-ref refid="bib13">[13]</ce:cross-ref>
						and from adherent cell lines by incubation of RIPA extraction
						buffer including protease inhibitor cocktail (Calbiochem, San
						Diego, CA) on flasks over an ice bath for 5
						<ce:hsp sp="0.25" />
						min followed by cell scraping. Western blot analysis was conducted
						as previously described
						<ce:cross-ref refid="bib13">[13]</ce:cross-ref>
						. Briefly, proteins were quantified and loaded onto Bis-Tris 4–12%
						density gradient gels for SDS–PAGE. Proteins were transferred onto
						nitrocellulose and incubated with blocking buffer (5% bovine milk
						in Tris buffered saline plus 0.05% Tween 20). Membranes were
						probed with the following primary antibodies: anti-synaptophysin
						(1:400, Sigma); anti-cyclophilin A (1:2000, Upstate Biotech); or
						anti-MT5-MMPvar-produced for our laboratory and designed to be
						antigenic only to the 5′ region of MT5-MMPvar (1:2000, Primm
						Biotech). For peptide competition, anti-MT5-MMPvar antibody
						(1:2000) was pre-incubated with or without a peptide used to
						generate MT5-MMPvar antibody (1:200) in blocking buffer at 4
						<ce:hsp sp="0.25" />
						°C for 1
						<ce:hsp sp="0.25" />
						h prior to primary antibody incubation. Following incubation with
						secondary antibody, immunopositive proteins were detected by
						autoradiography using ECL reagents (Amersham Pharmacia Biotech,
						Piscataway NJ) and quantitated with densitometry where indicated.
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>2.4</ce:label>
					<ce:section-title>Cloning of a novel MT5-MMP transcript</ce:section-title>
					<ce:para>
						Total RNA was isolated from NT2 cells (TRIzol reagent) and used (1
						<ce:hsp sp="0.25" />
						μg) as a template for reverse transcription (RT). RT product was
						PCR amplified using primers specific for human MT5-MMP cDNA (
						<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
						B) and Advantage GCII DNA polymerase system (Clontech, Mountain
						View, CA) with the following cycling conditions: 1
						<ce:hsp sp="0.25" />
						min at 92
						<ce:hsp sp="0.25" />
						°C followed by 1
						<ce:hsp sp="0.25" />
						min at 92
						<ce:hsp sp="0.25" />
						°C, 1
						<ce:hsp sp="0.25" />
						min at 70
						<ce:hsp sp="0.25" />
						°C, 3
						<ce:hsp sp="0.25" />
						min at 72
						<ce:hsp sp="0.25" />
						°C for 35 cycles, and final extension for 10
						<ce:hsp sp="0.25" />
						min at 72
						<ce:hsp sp="0.25" />
						°C. PCR product was cloned into pTARGET eukaryotic expression
						vector (Promega, Madison, Wisconsin) and sequenced (VCU Nucleic
						Acid Research Facility and University of Iowa Sequencing
						Facility). Sequence analysis and alignment was performed online
						using available software and databases (Chromas, NCBI, Clustal).
						The resultant sequence was submitted to the NCBI database (GenBank
						Accession No.
						<ce:inter-ref xlink:href="genbank:DQ300264"
							xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">DQ300264</ce:inter-ref>
						).
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>2.5</ce:label>
					<ce:section-title>RT- PCR of the 5′ end of MT5-MMP</ce:section-title>
					<ce:para>
						Total RNA was obtained as described above and reverse
						transcription (RT) performed (Invitrogen, Superscript II). RT
						product was amplified (Clontech, Advantage GCII DNA Polymerase)
						using primers specific for the 5′ end of the MT5-MMP gene (
						<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
						C) and the following cycling conditions: 1
						<ce:hsp sp="0.25" />
						min at 92
						<ce:hsp sp="0.25" />
						°C followed by 30
						<ce:hsp sp="0.25" />
						s at 92
						<ce:hsp sp="0.25" />
						°C, 30
						<ce:hsp sp="0.25" />
						s at 69
						<ce:hsp sp="0.25" />
						°C, 1
						<ce:hsp sp="0.25" />
						min at 72
						<ce:hsp sp="0.25" />
						°C for 35 cycles, and final extension for 3
						<ce:hsp sp="0.25" />
						mins at 72
						<ce:hsp sp="0.25" />
						°C.
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>2.6</ce:label>
					<ce:section-title>In vitro transcription/translation</ce:section-title>
					<ce:para>
						MT5-MMPvar cDNA (sequence confirmed) was subcloned into pCRT7/CT
						(Invitrogen, Carlsbad, CA), containing a 3–5
						<ce:hsp sp="0.25" />
						kDa C-terminal tag fusion protein (
						<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
						A). DNA constructs were transformed into BL21Dea3pLysS bacteria
						and treated with 1
						<ce:hsp sp="0.25" />
						μM IPTG for 0–6
						<ce:hsp sp="0.25" />
						h to induce protein expression. Proteins were isolated and
						prepared for Western blot analysis as described. An antibody
						against the V5 epitope found on the C-terminal tag was used for
						detection (1:2000, Invitrogen).
					</ce:para>
				</ce:section>
			</ce:section>
			<ce:section>
				<ce:label>3</ce:label>
				<ce:section-title>Results</ce:section-title>
				<ce:section>
					<ce:label>3.1</ce:label>
					<ce:section-title>MT5-MMP mRNA levels are significantly increased
						in NT2 cells following neuronal differentiation</ce:section-title>
					<ce:para>
						The temporal expression pattern of MT5-MMP in rodent neural
						development and its expression in adult rodent hippocampal neurons
						have been reported
						<ce:cross-refs refid="bib7 bib9">[7,9]</ce:cross-refs>
						. The purpose of our studies was to begin investigations into the
						potential role of MT5-MMP in neurogenesis and to expand on
						previous findings in adult human brain tissue
						<ce:cross-ref refid="bib12">[12]</ce:cross-ref>
						. We first examined MT5-MMP mRNA expression in an in vitro model
						of adult neurogenesis and neuronal differentiation. Using an
						established protocol, multipotent NT2 cells were differentiated
						into neuronal (hNT) cells (
						<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>
						<ce:float-anchor refid="fig1" />
						A and B) verified by synaptophysin immunoblotting (
						<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>
						C). Total RNA isolated from NT2 and hNT cells was subjected to
						qPCR analysis using primers specific for MT5-MMP (
						<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
						A). mRNA levels were modest in NT2 cells and significantly (
						<ce:italic>P</ce:italic>
						<ce:hsp sp="0.25" />
						&lt;
						<ce:hsp sp="0.25" />
						0.003) higher in differentiated hNT cells (
						<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>
						D). Relative values of NT2 and hNT RNA were normalized to the
						housekeeping gene, cyclophilin A.
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>3.2</ce:label>
					<ce:section-title>An MT5-MMP transcript cloned from NT2 cells does
						not share full sequence homology with the previously reported
						sequence</ce:section-title>
					<ce:para>
						In order to perform functional and expression studies, we cloned
						the full length cDNA of MT5-MMP (
						<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>
						<ce:float-anchor refid="fig2" />
						A) from NT2 cells using primers specific for the published human
						MT5-MMP gene (
						<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
						B). Once subcloned into pTARGET expression vector, the cDNA was
						sequenced and alignment analysis was performed. Results from
						sequence analysis showed that the obtained sequence (MT5-MMPvar)
						had a 92% sequence homology with that of the published sequence of
						human MT5-MMP (
						<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>
						B). To determine the location and nature of the divergent DNA
						sequence, differences in sequence identity were plotted to the
						corresponding domain feature of the protein (
						<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>
						C). Analysis of MT5-MMPvar revealed a 162
						<ce:hsp sp="0.25" />
						bp deletion corresponding to an area within the signal and
						propeptide domains. A significant portion of the signal peptide
						(39 amino acids of 52) was deleted as well as the first nine amino
						acid residues of the propeptide. Additionally, a single amino acid
						substitution in the hemopexin-like domain (Y to H) was observed.
						Additional database analysis (PredictProtein program of ExPASy
						Proteomic tools, SignalP, Phobius) indicated that while no
						significant functional motif of the propeptide domain was deleted;
						(1) the truncated signal domain was predicted to result in loss of
						a signal peptide sequence for direction to the endoplasmic
						reticulum and (2) MT5-MMPvar was predicted to associate with the
						membrane in the correct orientation, as a type-1 transmembrane
						protein.
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>3.3</ce:label>
					<ce:section-title>Two MT5-MMP transcripts can be identified in NT2
						cells, hNT cells and adult human brain tissue</ce:section-title>
					<ce:para>
						To analyze further the 5′ region of the MT5-MMP gene sequence,
						primers were designed to amplify the divergent region (
						<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>
						C). Expected bands at 978 and 1140
						<ce:hsp sp="0.25" />
						bp represented MT5-MMPvar and MT5-MMP transcripts, respectively.
						Results from RT-PCR analysis demonstrated the presence of both
						transcripts in NT2 cells, hNT cells, and in adult human brain
						samples (
						<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref>
						<ce:float-anchor refid="fig3" />
						).
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>3.4</ce:label>
					<ce:section-title>
						MT5-MMPvar cDNA subcloned into a bacterial expression system
						translates into a ∼55
						<ce:hsp sp="0.25" />
						kDa protein
					</ce:section-title>
					<ce:para>
						In order to determine if the cDNA obtained was capable of
						translating into a protein, MT5-MMPvar cDNA was subcloned into an
						in vitro transcription/translation system to generate a fusion
						protein containing a C-terminus tag (
						<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
						<ce:float-anchor refid="fig4" />
						A). Induction of MT5-MMP protein expression in bacterial cells
						with IPTG resulted in the translation of a ∼55
						<ce:hsp sp="0.25" />
						kDa protein, detected using an antibody directed against the V5
						epitope, which adds 3–5
						<ce:hsp sp="0.25" />
						kDa to the protein (
						<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
						B). To confirm that the variant protein product could be detected
						in the cells of origin, an antibody made using a peptide sequence
						spanning the deleted region of MT5-MMPvar transcript (
						<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>
						B, shaded box) was utilized. This sequence (PGPRRAVARADEAEA) was
						designed and produced (Primm Biotech) to correspond to the four
						amino acids before and the eleven amino acids following the region
						deleted from MT5-MMP. Western blot analysis of NT2 and hNT protein
						using this antibody confirmed the presence of the MT5-MMPvar
						protein product (
						<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
						C, left panel). Antibody specificity was demonstrated by peptide
						competition using the purified peptide corresponding to the
						sequence of the MT5-MMPvar-specific antibody (
						<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
						C, right panel; 55
						<ce:hsp sp="0.25" />
						kDa bands). Densitometric quantitation revealed an increase in
						MT5-MMPvar protein in hNT cells over NT2 levels (
						<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
						D). In all experiments, cyclophilin A was used as an internal
						control (
						<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
						C, right panel; 17
						<ce:hsp sp="0.25" />
						kDa bands).
					</ce:para>
				</ce:section>
				<ce:section>
					<ce:label>3.5</ce:label>
					<ce:section-title>MT5-MMPvar protein is expressed in adult human
						neurogenic regions</ce:section-title>
					<ce:para>
						We next sought to determine the presence of MT5-MMPvar protein in
						neurogenic adult human brain tissue. Western blot analysis, using
						the above mentioned deletion spanning antibody, revealed the
						presence of MT5-MMPvar protein in six independent hippocampi
						obtained from temporal lobe resection (
						<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>
						<ce:float-anchor refid="fig5" />
						A, lanes 1–6, top panel). Peptide competition confirmed antibody
						specificity by blocking the endogenous ∼52
						<ce:hsp sp="0.25" />
						kDa protein species (
						<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>
						B). NT2 cell lysate was used as positive control (
						<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>
						A, lane 7). Cyclophilin A was used as an internal control (
						<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>
						).
					</ce:para>
				</ce:section>
			</ce:section>
			<ce:section>
				<ce:label>4</ce:label>
				<ce:section-title>Discussion</ce:section-title>
				<ce:para>
					Due to published reports on the temporal expression of MT5-MMP in
					the rodent nervous system
					<ce:cross-ref refid="bib7">[7]</ce:cross-ref>
					, and the potential role of this gene in adult neuroplasticity
					<ce:cross-ref refid="bib10">[10]</ce:cross-ref>
					, we sought to clone this gene for functional as well as expression
					studies relating to adult human neurogenesis. Levels of total
					MT5-MMP mRNA in differentiated hNT cells are significantly higher
					than that seen in NT2 cells (
					<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>
					D). cDNA subsequently cloned from NT2 cells shares a 92% homology
					to the reported MT5-MMP sequence (
					<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>
					B). Compared to the reported MT5-MMP, this novel transcript
					contains a deletion containing part of the signal peptide region
					spanning into the propeptide domain. The cDNA amino terminus of
					both the previously reported MT5-MMP transcript and this novel
					MT5-MMP transcript were identified in NT2 cells, hNT cells, and in
					adult human brain tissue (
					<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref>
					); however, in this cell line we were unable to clone the full cDNA
					of the published MT5-MMP sequence (
					<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>
					A). It should be noted that quantitative results in
					<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>
					correspond to total MT5-MMP mRNA levels as the gene was probed
					using primers to a region common to both transcripts. Quantitative
					analysis of the relative expression levels of the two transcripts
					using Taqman real-time PCR was not performed due to sequence
					limitations surrounding the deleted region of MT5-MMPvar. This
					flanking DNA sequence consists of a small intron-spanning region of
					high GC content which was not adequate for the design of
					quantitative real-time PCR primers. MT5-MMPvar cDNA was shown to
					translate into a full length protein (
					<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
					B). Quantitation of the detected MT5-MMPvar protein using a custom
					MT5-MMPvar antibody shows an increase in MT5-MMPvar protein in hNT
					cells (
					<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>
					D).
				</ce:para>
				<ce:para>
					In this report, we used a start codon located upstream from that
					which was previously reported for PCR-based cDNA cloning (12).
					Kajita et al. have reported similar findings for variable MT4-MMP
					transcripts, in which a second transcript was found to encode a
					more highly transcribed sequence and the only translated protein
					product
					<ce:cross-ref refid="bib14">[14]</ce:cross-ref>
					. The results presented here indicate that multiple gene products
					from the human MT5-MMP gene may exist and that this newly described
					transcript is expressed in human CNS tissue. Indeed, MT5-MMPvar
					protein was found to be expressed in six independent human
					hippocampal samples (
					<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>
					). Our results demonstrating the over-expression of MT5-MMPvar in
					differentiated human hNT neurons are in agreement with that of
					Sekine-Aizawa et al.
					<ce:cross-ref refid="bib9">[9]</ce:cross-ref>
					in which the authors report the localization of MT5-MMP to neurons
					in the rodent CNS. The significance of the 162
					<ce:hsp sp="0.25" />
					bp deletion is not known; however, it is interesting that this
					deletion corresponds to a region of trinucleotide repeats
					containing eight Pro, six Leu, and six Ala in the reported
					sequence. It has been proposed that this area could give rise to
					protein variants due to the instability known to be associated with
					such repeats
					<ce:cross-ref refid="bib12">[12]</ce:cross-ref>
					. As database analysis predicts the loss of functional signal
					peptide, future studies aim to empirically determine the functional
					consequence of this loss. Taken together these studies support the
					further characterization of this gene and its protein products.
				</ce:para>
			</ce:section>
		</ce:sections>
		<ce:acknowledgment xmlns:ce="http://www.elsevier.com/xml/common/dtd">
			<ce:section-title>Acknowledgements</ce:section-title>
			<ce:para>We are grateful for the excellent technical assistance of
				Pam Gigliotti. In addition we are indebted to Dr. Harold Young for
				his continued support of our research and to Dr. K. Holloway and the
				Hirshler foundation for their financial support of this work.</ce:para>
		</ce:acknowledgment>
	</body>
	<tail>
		<ce:bibliography xmlns:ce="http://www.elsevier.com/xml/common/dtd">
			<ce:section-title>References</ce:section-title>
			<ce:bibliography-sec>
				<ce:bib-reference id="bib1">
					<ce:label>[1]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>V.W.</ce:given-name>
									<ce:surname>Yong</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>C.A.</ce:given-name>
									<ce:surname>Krekoski</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>P.A.</ce:given-name>
									<ce:surname>Forsythe</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>R.</ce:given-name>
									<ce:surname>Bell</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>D.R.</ce:given-name>
									<ce:surname>Edwards</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Matrix metalloproteinases and diseases of the CNS</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>TINS</sb:maintitle>
									</sb:title>
									<sb:volume-nr>21</sb:volume-nr>
								</sb:series>
								<sb:issue-nr>2</sb:issue-nr>
								<sb:date>1998</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>75</sb:first-page>
								<sb:last-page>80</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib2">
					<ce:label>[2]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>A.</ce:given-name>
									<ce:surname>Lukes</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>S.</ce:given-name>
									<ce:surname>Mun-Bryce</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>M.</ce:given-name>
									<ce:surname>Lukes</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>G.A.</ce:given-name>
									<ce:surname>Rosenberg</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Extracellular matrix degradation by
									metalloproteinases and central nervous system diseases</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Mol. Neurobiol.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>19</sb:volume-nr>
								</sb:series>
								<sb:issue-nr>3</sb:issue-nr>
								<sb:date>1999</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>267</sb:first-page>
								<sb:last-page>284</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib3">
					<ce:label>[3]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>M.</ce:given-name>
									<ce:surname>Egeblad</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>Z.</ce:given-name>
									<ce:surname>Werb</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>New functions for the matrix metalloproteinases in
									cancer progression</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Nat. Rev. Cancer</sb:maintitle>
									</sb:title>
									<sb:volume-nr>2</sb:volume-nr>
								</sb:series>
								<sb:date>2002</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>161</sb:first-page>
								<sb:last-page>174</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib4">
					<ce:label>[4]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>R.P.</ce:given-name>
									<ce:surname>Somerville</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>S.A.</ce:given-name>
									<ce:surname>Oblander</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>S.S.</ce:given-name>
									<ce:surname>Apte</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Matrix metalloproteinases: old dogs with new
									tricks</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Genome Biol.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>4</sb:volume-nr>
								</sb:series>
								<sb:issue-nr>3</sb:issue-nr>
								<sb:date>2003</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>216</sb:first-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib5">
					<ce:label>[5]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>L.</ce:given-name>
									<ce:surname>McCawley</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>L.</ce:given-name>
									<ce:surname>Matrisian</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Matrix metalloproteinases: they’re not just for
									matrix anymore!</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Curr. Opin. Cell Biol.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>13</sb:volume-nr>
								</sb:series>
								<sb:date>2001</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>534</sb:first-page>
								<sb:last-page>540</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib6">
					<ce:label>[6]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>H.L.</ce:given-name>
									<ce:surname>Fillmore</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>T.</ce:given-name>
									<ce:surname>Van Meter</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>W.C.</ce:given-name>
									<ce:surname>Broaddus</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Membrane-type matrix metalloproteinases (MT-MMPs):
									expression and function during glioma invasion</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>J. Neuro-Oncol.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>53</sb:volume-nr>
								</sb:series>
								<sb:date>2001</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>187</sb:first-page>
								<sb:last-page>202</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib7">
					<ce:label>[7]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>D.M.</ce:given-name>
									<ce:surname>Jaworski</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Developmental regulation of membrane-type 5 matrix
									metalloproteinase (MT5-MMP) expression in the rat nervous
									system</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Brain Res.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>860</sb:volume-nr>
								</sb:series>
								<sb:date>2000</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>174</sb:first-page>
								<sb:last-page>177</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib8">
					<ce:label>[8]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>D.</ce:given-name>
									<ce:surname>Pei</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Identification and characterization of the fifth
									membrane-type matrix metalloproteinase MT5-MMP</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>JBC</sb:maintitle>
									</sb:title>
									<sb:volume-nr>274</sb:volume-nr>
								</sb:series>
								<sb:issue-nr>13</sb:issue-nr>
								<sb:date>1999</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>8925</sb:first-page>
								<sb:last-page>8932</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib9">
					<ce:label>[9]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>Y.</ce:given-name>
									<ce:surname>Sekine-Aizawa</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>E.</ce:given-name>
									<ce:surname>Hama</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>K.</ce:given-name>
									<ce:surname>Watanbe</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>S.</ce:given-name>
									<ce:surname>Tsubuki</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>M.</ce:given-name>
									<ce:surname>Kanai-Azuma</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>Y.</ce:given-name>
									<ce:surname>Kanai</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>H.</ce:given-name>
									<ce:surname>Arai</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>H.</ce:given-name>
									<ce:surname>Aizawa</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>N.</ce:given-name>
									<ce:surname>Iwata</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>T.C.</ce:given-name>
									<ce:surname>Saido</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Matrix metalloproteinase (MMP) system in brain:
									identification and characterization of brain-specific MMP
									highly expressed in cerebellum</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Eur. J. Neurosci.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>13</sb:volume-nr>
								</sb:series>
								<sb:date>2001</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>935</sb:first-page>
								<sb:last-page>948</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib10">
					<ce:label>[10]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>H.</ce:given-name>
									<ce:surname>Hayashita-Kinoh</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>H.</ce:given-name>
									<ce:surname>Kinoh</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>A.</ce:given-name>
									<ce:surname>Okada</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>K.</ce:given-name>
									<ce:surname>Komori</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>Y.</ce:given-name>
									<ce:surname>Itoh</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>T.</ce:given-name>
									<ce:surname>Chiba</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>M.</ce:given-name>
									<ce:surname>Kajita</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>I.</ce:given-name>
									<ce:surname>Yana</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>M.</ce:given-name>
									<ce:surname>Seiki</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Membrane-type 5 matrix metalloproteinase is
									expressed in differentiated neurons and regulates axonal growth</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Cell Growth Differ.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>12</sb:volume-nr>
								</sb:series>
								<sb:date>2001</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>573</sb:first-page>
								<sb:last-page>580</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib11">
					<ce:label>[11]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>S.J.</ce:given-name>
									<ce:surname>Pleasure</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>C.</ce:given-name>
									<ce:surname>Page</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>V.M.</ce:given-name>
									<ce:surname>Lee</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Pure, postmitotic, polarized human neurons derived
									from NTera 2 cells provide a system for expressing exogenous
									proteins in terminally differentiated neurons</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>J. Neurosci.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>12</sb:volume-nr>
								</sb:series>
								<sb:issue-nr>5</sb:issue-nr>
								<sb:date>1992</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>1802</sb:first-page>
								<sb:last-page>1815</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib12">
					<ce:label>[12]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>E.</ce:given-name>
									<ce:surname>Llano</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>A.M.</ce:given-name>
									<ce:surname>Pendas</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>J.P.</ce:given-name>
									<ce:surname>Freije</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>A.</ce:given-name>
									<ce:surname>Nakano</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>V.</ce:given-name>
									<ce:surname>Knauper</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>G.</ce:given-name>
									<ce:surname>Murphy</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>C.</ce:given-name>
									<ce:surname>Lopez-Otin</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Identification and characterization of human
									MT5-MMP, a new membrane-bound activator of progelatinase a
									overexpressed in brain tumors</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Cancer Res.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>59</sb:volume-nr>
								</sb:series>
								<sb:date>1999</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>2570</sb:first-page>
								<sb:last-page>2576</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib13">
					<ce:label>[13]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>T.</ce:given-name>
									<ce:surname>Tsukatani</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>H.L.</ce:given-name>
									<ce:surname>Fillmore</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>H.R.</ce:given-name>
									<ce:surname>Hamilton</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>E.H.</ce:given-name>
									<ce:surname>Holbrook</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>R.M.</ce:given-name>
									<ce:surname>Costanzo</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Matrix metalloproteinase expression in the
									olfactory epithelium</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>Neuroreport</sb:maintitle>
									</sb:title>
									<sb:volume-nr>14</sb:volume-nr>
								</sb:series>
								<sb:issue-nr>8</sb:issue-nr>
								<sb:date>2003</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>1135</sb:first-page>
								<sb:last-page>1140</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
				<ce:bib-reference id="bib14">
					<ce:label>[14]</ce:label>
					<sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
						<sb:contribution>
							<sb:authors>
								<sb:author>
									<ce:given-name>M.</ce:given-name>
									<ce:surname>Kajita</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>H.</ce:given-name>
									<ce:surname>Kinoh</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>N.</ce:given-name>
									<ce:surname>Ito</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>A.</ce:given-name>
									<ce:surname>Takamura</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>Y.</ce:given-name>
									<ce:surname>Itoh</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>A.</ce:given-name>
									<ce:surname>Okada</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>H.</ce:given-name>
									<ce:surname>Sato</ce:surname>
								</sb:author>
								<sb:author>
									<ce:given-name>M.</ce:given-name>
									<ce:surname>Seiki</ce:surname>
								</sb:author>
							</sb:authors>
							<sb:title>
								<sb:maintitle>Human membrane type-4 matrix metalloproteinase
									(MT4-MMP) is encoded by a novel major transcript: isolation of
									complementary DNA clones for human and mouse MT4-MMP
									transcripts</sb:maintitle>
							</sb:title>
						</sb:contribution>
						<sb:host>
							<sb:issue>
								<sb:series>
									<sb:title>
										<sb:maintitle>FEBS Lett.</sb:maintitle>
									</sb:title>
									<sb:volume-nr>457</sb:volume-nr>
								</sb:series>
								<sb:issue-nr>3</sb:issue-nr>
								<sb:date>1999</sb:date>
							</sb:issue>
							<sb:pages>
								<sb:first-page>353</sb:first-page>
								<sb:last-page>356</sb:last-page>
							</sb:pages>
						</sb:host>
					</sb:reference>
				</ce:bib-reference>
			</ce:bibliography-sec>
		</ce:bibliography>
	</tail>
</article>
